Allstate (ALL) Expected to Announce Earnings on Wednesday

Allstate (NYSE:ALL) is expected to be releasing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Allstate to post earnings of $6.06 per share and revenue of $15.4583 billion for the quarter. Investors can check the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, August 6, 2026 at 9:00 AM ET.

Allstate Stock Performance

Shares of ALL stock opened at $263.13 on Tuesday. The company has a market capitalization of $67.73 billion, a price-to-earnings ratio of 5.80, a price-to-earnings-growth ratio of 0.45 and a beta of 0.16. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.36 and a current ratio of 0.36. Allstate has a one year low of $188.08 and a one year high of $277.22. The company’s 50-day moving average is $236.87 and its 200 day moving average is $218.58.

Allstate Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Monday, August 31st will be issued a dividend of $1.08 per share. The ex-dividend date is Monday, August 31st. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.6%. Allstate’s dividend payout ratio is presently 9.53%.

Insiders Place Their Bets

In related news, insider Mark Q. Prindiville sold 1,550 shares of Allstate stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $216.27, for a total transaction of $335,218.50. Following the transaction, the insider directly owned 27,558 shares in the company, valued at approximately $5,959,968.66. The trade was a 5.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Andrea Redmond sold 2,225 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $202.91, for a total value of $451,474.75. Following the sale, the director directly owned 2,225 shares of the company’s stock, valued at $451,474.75. This represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 1.55% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ALL. State Street Corp raised its stake in Allstate by 3.7% during the 4th quarter. State Street Corp now owns 12,297,551 shares of the insurance provider’s stock worth $2,571,600,000 after acquiring an additional 438,034 shares during the period. GQG Partners LLC increased its stake in shares of Allstate by 36.0% in the fourth quarter. GQG Partners LLC now owns 5,488,560 shares of the insurance provider’s stock worth $1,142,449,000 after purchasing an additional 1,452,993 shares in the last quarter. Boston Partners raised its position in shares of Allstate by 14.9% during the 3rd quarter. Boston Partners now owns 3,050,780 shares of the insurance provider’s stock valued at $654,652,000 after purchasing an additional 395,195 shares during the period. Raymond James Financial Inc. lifted its stake in shares of Allstate by 3.3% during the 2nd quarter. Raymond James Financial Inc. now owns 2,793,645 shares of the insurance provider’s stock valued at $562,388,000 after buying an additional 88,620 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Allstate by 1.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,650,356 shares of the insurance provider’s stock valued at $551,682,000 after buying an additional 43,905 shares in the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. Roth Capital reissued a “buy” rating and set a $275.00 price target on shares of Allstate in a research report on Friday, July 17th. Zacks Research downgraded Allstate from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 7th. Cantor Fitzgerald lifted their target price on Allstate from $236.00 to $242.00 and gave the stock a “neutral” rating in a report on Thursday, July 9th. Keefe, Bruyette & Woods upped their price target on Allstate from $242.00 to $255.00 and gave the company a “market perform” rating in a report on Wednesday, July 8th. Finally, Barclays boosted their target price on Allstate from $203.00 to $213.00 and gave the stock an “underweight” rating in a research report on Tuesday, July 7th. Three research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $254.80.

About Allstate

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.